Magnitude of risks and benefits of the addition of bevacizumab to chemotherapy for advanced breast cancer patients: Meta-regression analysis of randomized trialsFederica Cuppone, Francesco Cognetti, Vanja Vaccaro et al.|Journal of Experimental & Clinical Cancer Research|2011Cited by 31